{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:20:52Z","timestamp":1785860452262,"version":"3.56.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.pain.2006.04.014","type":"journal-article","created":{"date-parts":[[2006,5,9]],"date-time":"2006-05-09T13:09:17Z","timestamp":1147180157000},"page":"315-325","source":"Crossref","is-referenced-by-count":135,"title":["The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization"],"prefix":"10.1097","volume":"122","author":[{"given":"Parisa","family":"Gazerani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Staahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asbj\u00f8n M.","family":"Drewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Arendt-Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"5","key":"R2-13-20210112","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","article-title":"Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A.","volume":"26","author":"Aoki","year":"2005","journal-title":"Neurotoxicology"},{"key":"R5-13-20210112","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev.med.55.091902.104440","article-title":"Botulinum toxin and other new approaches to migraine therapy.","volume":"55","author":"Ashkenazi","year":"2004","journal-title":"Annu Rev Med"},{"issue":"3","key":"R6-13-20210112","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/01.wco.0000073935.19076.47","article-title":"The evolving management of migraine.","volume":"16","author":"Ashkenazi","year":"2003","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"R7-13-20210112","first-page":"201","article-title":"Antinociceptive effect of Botulinum toxin type A in rat model of carrageenan and capsaicin induced pain.","volume":"46","author":"Bach-Rojecky","year":"2005","journal-title":"Croat Med J"},{"key":"R8-13-20210112","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00702-004-0265-1","article-title":"Botulinum toxine type A in experimental neuropathic pain.","volume":"112","author":"Bach-Rojecky","year":"2005","journal-title":"J Neural Transm"},{"issue":"11","key":"R9-13-20210112","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1524-4725.1998.tb04098.x","article-title":"Treatment of hyperfunctional lines of the face with botulinum toxin A.","volume":"24","author":"Binder","year":"1998","journal-title":"Dermatol Surg"},{"issue":"1","key":"R10-13-20210112","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-510X(02)00313-1","article-title":"Botulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study.","volume":"205","author":"Blersch","year":"2002","journal-title":"J Neurol Sci"},{"issue":"8","key":"R11-13-20210112","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1046\/j.1526-4610.2003.03167.x","article-title":"Procedures for administering botulinum toxin type A for migraine and tension-type headache.","volume":"43","author":"Blumenfeld","year":"2003","journal-title":"Headache"},{"issue":"2","key":"R12-13-20210112","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0304-3959(92)90258-D","article-title":"Cervicogenic headache, migraine, and tension-type headache. Pressure-pain threshold measurements.","volume":"51","author":"Bovim","year":"1992","journal-title":"Pain"},{"issue":"4","key":"R13-13-20210112","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.870020402","article-title":"Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.","volume":"2","author":"Brin","year":"1987","journal-title":"Mov Disord"},{"key":"R14-13-20210112","first-page":"421","article-title":"Botox for migraine: double-blind, placebo controlled region-specific evaluation.","volume":"20","author":"Brin","year":"2000","journal-title":"Cephalalgia"},{"issue":"5","key":"R16-13-20210112","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N","article-title":"An association between migraine and cutaneous allodynia.","volume":"47","author":"Burstein","year":"2000","journal-title":"Ann Neurol"},{"issue":"2-3","key":"R17-13-20210112","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3959(00)00478-4","article-title":"Deconstructing migraine headache into peripheral and central sensitization.","volume":"89","author":"Burstein","year":"2001","journal-title":"Pain"},{"issue":"1","key":"R18-13-20210112","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ana.10786","article-title":"Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.","volume":"55","author":"Burstein","year":"2004","journal-title":"Ann Neurol"},{"issue":"1","key":"R19-13-20210112","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-3959(94)90048-5","article-title":"Botulinum toxin in the treatment of myofascial pain syndrome.","volume":"59","author":"Cheshire","year":"1994","journal-title":"Pain"},{"issue":"5","key":"R20-13-20210112","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11916-001-0051-9","article-title":"Interventional approaches to the management of myofacial pain syndrome.","volume":"5","author":"Criscuolo","year":"2001","journal-title":"Curr Pain Headache Rep"},{"issue":"3","key":"R21-13-20210112","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1468-1331.2004.00791.x","article-title":"EFNS guidelines on neuropathic pain assessment.","volume":"11","author":"Cruccu","year":"2004","journal-title":"Eur J Neurol"},{"issue":"1-2","key":"R22-13-20210112","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","article-title":"Subcutaneous administration of botulinum toxin A reduces formalin-induced pain.","volume":"107","author":"Cui","year":"2004","journal-title":"Pain"},{"issue":"38","key":"R26-13-20210112","doi-asserted-by":"crossref","first-page":"34846","DOI":"10.1074\/jbc.M202902200","article-title":"Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin.","volume":"277","author":"Duggan","year":"2002","journal-title":"J Biol Chem"},{"issue":"1","key":"R27-13-20210112","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4610.2004.04007.x","article-title":"Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implication for migraine therapy.","volume":"44","author":"Durham","year":"2004","journal-title":"Headache"},{"issue":"9","key":"R28-13-20210112","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1523\/JNEUROSCI.19-09-03423.1999","article-title":"Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug.","volume":"19","author":"Durham","year":"1999","journal-title":"J Neurosci"},{"key":"R29-13-20210112","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0141-5425(91)90125-Q","article-title":"A laser Doppler scanner for imaging blood flow in skin.","volume":"13","author":"Essex","year":"1991","journal-title":"J Biomed Eng"},{"issue":"9","key":"R30-13-20210112","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1468-2982.2002.00390.x","article-title":"Treatment of headache with botulinum toxin A - a review according to evidence-based medicine criteria.","volume":"22","author":"Evers","year":"2002","journal-title":"Cephalalgia"},{"issue":"3","key":"R31-13-20210112","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11916-003-0078-1","article-title":"Is there a role for botulinum toxin in the treatment of migraine?","volume":"7","author":"Evers","year":"2003","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"R32-13-20210112","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0304-3959(87)90089-3","article-title":"Pressure algometry over normal muscles. Standard values, validity and reproducibility of pressure threshold.","volume":"30","author":"Fischer","year":"1987","journal-title":"Pain"},{"issue":"3","key":"R33-13-20210112","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0304-3959(87)90074-1","article-title":"Reliability of the pressure algometer as a measure of myofascial trigger point sensitivity.","volume":"28","author":"Fischer","year":"1987","journal-title":"Pain"},{"key":"R34-13-20210112","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0304-3940(94)11218-8","article-title":"Neurogenic flare responses are heterogeneous in superficial and deep layers of human skin.","volume":"185","author":"Forster","year":"1995","journal-title":"Neurosci Lett"},{"key":"R35-13-20210112","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1115\/1.3426253","article-title":"Thermography as a means of blood perfusion measurement.","volume":"101","author":"Francis","year":"1979","journal-title":"J Biomech Eng"},{"issue":"4","key":"R36-13-20210112","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJMra010917","article-title":"Migraine-current understanding and treatment.","volume":"346","author":"Goadsby","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"R37-13-20210112","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-3959(01)00292-5","article-title":"Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes.","volume":"91","author":"Gobel","year":"2001","journal-title":"Pain"},{"issue":"6","key":"R38-13-20210112","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11916-999-0069-y","article-title":"Mechanism of botulinum toxin in the relief of chronic pain.","volume":"3","author":"Guyer","year":"1999","journal-title":"Curr Rev Pain"},{"issue":"2","key":"R39-13-20210112","first-page":"143","article-title":"Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons.","volume":"43","author":"Holzer","year":"1991","journal-title":"Pharmacol Rev"},{"issue":"2","key":"R40-13-20210112","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0021-5155(99)00197-5","article-title":"Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles.","volume":"44","author":"Ishikawa","year":"2000","journal-title":"Jpn J Ophthalmol"},{"issue":"2","key":"R41-13-20210112","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1526-4637.2003.03013.x","article-title":"Botulinum toxin a improved burning pain and allodynia in two patients with spinal cord pathology.","volume":"4","author":"Jabbari","year":"2003","journal-title":"Pain Med"},{"issue":"7","key":"R42-13-20210112","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1526-4610.2005.05153.x","article-title":"Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1COX2 inhibitors.","volume":"45","author":"Jakubowski","year":"2005","journal-title":"Headache"},{"issue":"7","key":"R43-13-20210112","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jnnp.2003.034702","article-title":"Botulinum toxin in clinical practice.","volume":"75","author":"Jankovic","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"R44-13-20210112","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00296-004-0485-6","article-title":"Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome.","volume":"25","author":"Kamanli","year":"2004","journal-title":"Rheumatol Int"},{"issue":"6","key":"R45-13-20210112","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1161\/01.RES.77.6.1222","article-title":"Cutaneous active vasodilation in humans is mediated by cholinergic nerve cotransmission.","volume":"77","author":"Kellogg","year":"1995","journal-title":"Circ Res"},{"key":"R46-13-20210112","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1365-2133.2000.03839.x","article-title":"Effective treatment of frontal hyperhidrosis with Botulinum toxin A.","volume":"143","author":"Kinkelin","year":"2000","journal-title":"Br J Dermatol"},{"issue":"2","key":"R47-13-20210112","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0304-3959(92)90262-A","article-title":"Dynamic and static components of mechanical hyperalgesia in human hairy skin.","volume":"51","author":"Koltzenburg","year":"1992","journal-title":"Pain"},{"issue":"2","key":"R48-13-20210112","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00415-003-0971-x","article-title":"Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin.","volume":"250","author":"Kramer","year":"2003","journal-title":"J Neurol"},{"issue":"1","key":"R49-13-20210112","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1152\/jn.1991.66.1.190","article-title":"Neurogenic hyperalgesia psychophysical studies of underlying mechanisms.","volume":"66","author":"LaMotte","year":"1991","journal-title":"J Neurophysiol"},{"key":"R50-13-20210112","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1113\/jphysiol.1992.sp019068","article-title":"Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin.","volume":"448","author":"LaMotte","year":"1992","journal-title":"J Physiol"},{"key":"R51-13-20210112","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0304-3940(87)90281-3","article-title":"Laser Doppler measurements of skin vasodilation elicited by percutaneous electrical stimulation of nociceptors in humans.","volume":"82","author":"Magerl","year":"1987","journal-title":"Neurosci Lett"},{"issue":"1","key":"R53-13-20210112","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3959(97)00144-9","article-title":"Experimental cranial pain elicited by capsaicin: a PET study.","volume":"74","author":"May","year":"1998","journal-title":"Pain"},{"issue":"5","key":"R54-13-20210112","doi-asserted-by":"crossref","first-page":"H2124","DOI":"10.1152\/ajpheart.2001.281.5.H2124","article-title":"Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons.","volume":"281","author":"Morris","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"R55-13-20210112","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1468-2982.2004.00641.x","article-title":"Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study.","volume":"24","author":"Ondo","year":"2004","journal-title":"Cephalalgia"},{"issue":"11","key":"R56-13-20210112","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0006-2952(00)00260-4","article-title":"Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms.","volume":"59","author":"Purkiss","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"R57-13-20210112","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2133.1991.tb06035.x","article-title":"Measurement of cutaneous inflammatory reactions using a scanning laser Doppler velocimeter.","volume":"125","author":"Quinn","year":"1991","journal-title":"Br J Dermatol"},{"key":"R58-13-20210112","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1152\/jn.1998.80.6.2801","article-title":"Flare and hyperalgesia after intradermal capsaicin injection in human skin.","volume":"80","author":"Serra","year":"1998","journal-title":"J Neurophysiol"},{"issue":"7","key":"R59-13-20210112","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1468-2982.2002.00386.x","article-title":"Migraine: preventive treatment.","volume":"22","author":"Silberstein","year":"2002","journal-title":"Cephalalgia"},{"issue":"10","key":"R60-13-20210112","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1517\/14656566.2.10.1649","article-title":"Review of botulinum toxin type A and its clinical applications in migraine headache.","volume":"2","author":"Silberstein","year":"2001","journal-title":"Expert Opin Pharmacother"},{"issue":"9","key":"R61-13-20210112","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.4065\/80.9.1126","article-title":"BoNTA-039 Study Group. Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.","volume":"80","author":"Silberstein","year":"2005","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"R62-13-20210112","first-page":"155","article-title":"The origin, structure, and pharmacological activity of botulinum toxin.","volume":"33","author":"Simpson","year":"1981","journal-title":"Pharmacol Rev"},{"issue":"2","key":"R63-13-20210112","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1213\/01.ane.0000194447.46763.73","article-title":"A lack of antinociceptive or anti-inflammatory effect of botulinum toxin A in an inflammatory human pain model.","volume":"102","author":"Sycha","year":"2006","journal-title":"Anesth Analg"},{"issue":"8501","key":"R64-13-20210112","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","article-title":"Double-blind study of botulinum toxin in spasmodic torticollis.","volume":"2","author":"Tsui","year":"1986","journal-title":"Lancet"},{"issue":"3","key":"R65-13-20210112","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s10286-002-0026-x","article-title":"The role of gustatory flushing in Freys syndrome and its treatment with botulinum toxin type A.","volume":"12","author":"Tugnoli","year":"2002","journal-title":"Clin Auton Res"},{"issue":"7","key":"R66-13-20210112","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1212\/01.WNL.0000086374.92906.6A","article-title":"A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A.","volume":"61","author":"Voller","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"R67-13-20210112","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0041-0101(99)00153-1","article-title":"Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins.","volume":"38","author":"Welch","year":"2000","journal-title":"Toxicon"}],"container-title":["Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006396-200606000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:24:49Z","timestamp":1785857089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006396-200606000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pain.2006.04.014","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.14792.472322","asserted-by":"object"}]},"ISSN":["0304-3959"],"issn-type":[{"value":"0304-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}